(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.19%) $79.15
(-0.05%) $1.931
(0.88%) $2 331.30
(0.64%) $26.92
(1.04%) $964.80
(-0.46%) $0.933
(-0.62%) $11.03
(-0.31%) $0.798
(0.06%) $93.51
Live Chart Being Loaded With Signals
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States...
Stats | |
---|---|
Šios dienos apimtis | 138.00 |
Vidutinė apimtis | 1 132.00 |
Rinkos kapitalizacija | 97 450.00 |
EPS | $0 ( 2024-03-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-17 | Takeda Pharmaceutical Co Ltd | Sell | 1 000 000 | Series A Convertible Preferred Stock |
2023-01-27 | Pakianathan Deepika | Sell | 1 172 | Common Stock |
2023-01-23 | Sjogren Eric | Sell | 279 | Common Stock |
2023-01-23 | Kuriakose Emil | Sell | 79 | Common Stock |
2023-01-23 | Molineaux Susan | Sell | 526 | Common Stock |
INSIDER POWER |
---|
-51.26 |
Last 99 transactions |
Buy: 6 839 475 | Sell: 3 539 228 |
Calithera Biosciences Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
AUTL | 0.95 |
RMRM | 0.947 |
IZEA | 0.945 |
NGMS | 0.944 |
EFOI | 0.944 |
ADSE | 0.936 |
SMED | 0.933 |
THTX | 0.93 |
NBSE | 0.93 |
DMRC | 0.927 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
HZNP | -0.916 |
RXDX | -0.913 |
SUMR | -0.912 |
HWCC | -0.911 |
VBNK | -0.905 |
ARNA | -0.903 |
SKYX | -0.898 |
MLVF | -0.896 |
TTCF | -0.894 |
CPRX | -0.89 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Calithera Biosciences Inc Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $0 |
Bruto pelnas: | $0 (0.00 %) |
EPS: | $-3.78 |
FY | 2022 |
Pajamos: | $0 |
Bruto pelnas: | $0 (0.00 %) |
EPS: | $-3.78 |
FY | 2021 |
Pajamos: | $9.75M |
Bruto pelnas: | $9.75M (100.00 %) |
EPS: | $-31.16 |
FY | 2020 |
Pajamos: | $0.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-26.20 |
Financial Reports:
No articles found.
Calithera Biosciences Inc
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.